Arkolith/Insider Trading/GALT/Form 4

Shlevin Harold H.

DirectorGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Dec 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$177K
Net Open-Market Flow
-$177K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2025Option exercise(M)8K$4.16$35K20K
Dec 15, 2025Sell(S)8K$6.30$53K11K
Dec 12, 2025Sell(S)20K$6.27$124K11K
Dec 12, 2025Option exercise(M)20K$4.16$82K31K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2025Option exercise(M)8K—$00
Dec 12, 2025Option exercise(M)20K—$053K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-25-000064) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML